{"entity":{"type":"insider","cik":"0001402856","url":"/insider/0001402856","json_url":"/insider/0001402856.json","name":"McGaughy R Kent Jr","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":20,"first":"2016-06-01","last":"2021-10-19","span_basis":"filed_date"},"name_variants":[{"name":"McGaughy R Kent Jr","source":"filing","n_filings":20,"first_seen":"2016-06-01","last_seen":"2021-10-19"}],"transactions":[{"id":5289941,"accession":"0001140361-21-034925","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-21-034925","line_url":"/filing/0001140361-21-034925","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":683871.0,"shares_display":"683,871","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":5300000.25,"total_display":"5,300,000.25","total_whole":"5,300,000","shares_owned_after":2151209.0,"shares_owned_after_display":"2,151,209","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider","n_lines":3},{"id":5079374,"accession":"0001628280-21-018953","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-018953","line_url":"/filing/0001628280-21-018953#line-2","is_derivative":false,"issuer_cik":"0001372218","issuer_name":"PROCEPT BioRobotics Corp","issuer_ticker":"PRCT","issuer_name_source":null,"issuer_url":"/issuer/0001372218","owner_cik":null,"owner_name":"CPMG Inc; White Tailed Ptarmigan, LP; McGaughy R Kent Jr","owner_display_name":"CPMG Inc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440000.0,"shares_display":"440,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":11000000.0,"total_display":"11,000,000.00","total_whole":"11,000,000","shares_owned_after":11222662.0,"shares_owned_after_display":"11,222,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":5490008,"accession":"0001209191-21-023063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-023063","line_url":"/filing/0001209191-21-023063#line-3","is_derivative":false,"issuer_cik":"0001402856","issuer_name":"Instil Bio, Inc.","issuer_ticker":"TIL","issuer_name_source":null,"issuer_url":"/issuer/0001402856","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":9000000.0,"total_display":"9,000,000.00","total_whole":"9,000,000","shares_owned_after":8478790.0,"shares_owned_after_display":"8,478,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-23","filed_date":"2021-03-25","scope":"insider"},{"id":3168090,"accession":"0000905148-20-000826","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-20-000826","line_url":"/filing/0000905148-20-000826","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1780000.0,"shares_display":"1,780,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":2225000.0,"total_display":"2,225,000.00","total_whole":"2,225,000","shares_owned_after":1707208.0,"shares_owned_after_display":"1,707,208","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-07-21","scope":"insider","n_lines":3},{"id":7992452,"accession":"0000905148-19-001002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-19-001002","line_url":"/filing/0000905148-19-001002#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40218.0,"shares_display":"40,218","price_per_share":183.0,"price_display":"183.00","price_state":"stated","total_value":7359894.0,"total_display":"7,359,894.00","total_whole":"7,359,894","shares_owned_after":3063567.0,"shares_owned_after_display":"3,063,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6679047,"accession":"0000905148-18-000921","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000905148-18-000921","line_url":"/filing/0000905148-18-000921#line-5","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1418.0,"shares_display":"1,418","price_per_share":59.8952,"price_display":"59.90","price_state":"stated","total_value":84931.3936,"total_display":"84,931.39","total_whole":"84,931","shares_owned_after":3023349.0,"shares_owned_after_display":"3,023,349","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-12","scope":"insider"},{"id":6679044,"accession":"0000905148-18-000921","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-18-000921","line_url":"/filing/0000905148-18-000921#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52809.0,"shares_display":"52,809","price_per_share":60.0719,"price_display":"60.07","price_state":"stated","total_value":3172336.9671,"total_display":"3,172,336.97","total_whole":"3,172,337","shares_owned_after":3021931.0,"shares_owned_after_display":"3,021,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider"},{"id":6679041,"accession":"0000905148-18-000921","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-18-000921","line_url":"/filing/0000905148-18-000921","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56599.0,"shares_display":"56,599","price_per_share":58.77428468877542,"price_display":"58.77","price_state":"stated","total_value":3326565.7391,"total_display":"3,326,565.74","total_whole":"3,326,566","shares_owned_after":2969122.0,"shares_owned_after_display":"2,969,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider","n_lines":3},{"id":4753684,"accession":"0001140361-17-047823","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047823","line_url":"/filing/0001140361-17-047823#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":28.4715,"price_display":"28.47","price_state":"stated","total_value":484015.5,"total_display":"484,015.50","total_whole":"484,016","shares_owned_after":2912523.0,"shares_owned_after_display":"2,912,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2017-12-29","scope":"insider"},{"id":4500109,"accession":"0001140361-17-047649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-047649","line_url":"/filing/0001140361-17-047649#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":26.1,"price_display":"26.10","price_state":"stated","total_value":5220.0,"total_display":"5,220.00","total_whole":"5,220","shares_owned_after":2895523.0,"shares_owned_after_display":"2,895,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2017-12-28","scope":"insider"},{"id":4500104,"accession":"0001140361-17-047649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-047649","line_url":"/filing/0001140361-17-047649#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":25.8296,"price_display":"25.83","price_state":"stated","total_value":387444.0,"total_display":"387,444.00","total_whole":"387,444","shares_owned_after":2895323.0,"shares_owned_after_display":"2,895,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2017-12-28","scope":"insider"},{"id":4500099,"accession":"0001140361-17-047649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047649","line_url":"/filing/0001140361-17-047649#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":26.0605,"price_display":"26.06","price_state":"stated","total_value":312726.0,"total_display":"312,726.00","total_whole":"312,726","shares_owned_after":2880323.0,"shares_owned_after_display":"2,880,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":5346860,"accession":"0000905148-17-000940","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-17-000940","line_url":"/filing/0000905148-17-000940#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78275.0,"shares_display":"78,275","price_per_share":24.6528,"price_display":"24.65","price_state":"stated","total_value":1929697.92,"total_display":"1,929,697.92","total_whole":"1,929,698","shares_owned_after":2868323.0,"shares_owned_after_display":"2,868,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-15","scope":"insider"},{"id":5346853,"accession":"0000905148-17-000940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-17-000940","line_url":"/filing/0000905148-17-000940","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121725.0,"shares_display":"121,725","price_per_share":24.881564386937768,"price_display":"24.88","price_state":"stated","total_value":3028708.425,"total_display":"3,028,708.42","total_whole":"3,028,708","shares_owned_after":2789748.0,"shares_owned_after_display":"2,789,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-15","scope":"insider","n_lines":2},{"id":4409937,"accession":"0001179110-17-010716","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-17-010716","line_url":"/filing/0001179110-17-010716","is_derivative":false,"issuer_cik":"0001251769","issuer_name":"Apollo Endosurgery, Inc.","issuer_ticker":"APEN","issuer_name_source":null,"issuer_url":"/issuer/0001251769","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":454545.0,"shares_display":"454,545","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":2499997.5,"total_display":"2,499,997.50","total_whole":"2,499,998","shares_owned_after":469100.0,"shares_owned_after_display":"469,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider","n_lines":5},{"id":5346803,"accession":"0000905148-17-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-17-000017","line_url":"/filing/0000905148-17-000017#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9392.0,"shares_display":"9,392","price_per_share":21.7247,"price_display":"21.72","price_state":"stated","total_value":204038.3824,"total_display":"204,038.38","total_whole":"204,038","shares_owned_after":1926034.0,"shares_owned_after_display":"1,926,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-04","scope":"insider"},{"id":2361971,"accession":"0000905148-16-002140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-002140","line_url":"/filing/0000905148-16-002140#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":164753.0,"shares_display":"164,753","price_per_share":22.9909,"price_display":"22.99","price_state":"stated","total_value":3787819.7477,"total_display":"3,787,819.75","total_whole":"3,787,820","shares_owned_after":1916642.0,"shares_owned_after_display":"1,916,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider"},{"id":2417379,"accession":"0000905148-16-002130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-002130","line_url":"/filing/0000905148-16-002130#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":22.0498,"price_display":"22.05","price_state":"stated","total_value":59534.46,"total_display":"59,534.46","total_whole":"59,534","shares_owned_after":1751889.0,"shares_owned_after_display":"1,751,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"},{"id":2417374,"accession":"0000905148-16-002130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-002130","line_url":"/filing/0000905148-16-002130#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6189.0,"shares_display":"6,189","price_per_share":21.3651,"price_display":"21.37","price_state":"stated","total_value":132228.6039,"total_display":"132,228.60","total_whole":"132,229","shares_owned_after":1749189.0,"shares_owned_after_display":"1,749,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-14","filed_date":"2016-12-16","scope":"insider"},{"id":3200554,"accession":"0000905148-16-001850","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001850","line_url":"/filing/0000905148-16-001850#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105562.0,"shares_display":"105,562","price_per_share":17.323,"price_display":"17.32","price_state":"stated","total_value":1828650.526,"total_display":"1,828,650.53","total_whole":"1,828,651","shares_owned_after":1743000.0,"shares_owned_after_display":"1,743,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-18","scope":"insider"},{"id":3200550,"accession":"0000905148-16-001850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001850","line_url":"/filing/0000905148-16-001850#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":144058.0,"shares_display":"144,058","price_per_share":17.2626,"price_display":"17.26","price_state":"stated","total_value":2486815.6308,"total_display":"2,486,815.63","total_whole":"2,486,816","shares_owned_after":1637438.0,"shares_owned_after_display":"1,637,438","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-17","filed_date":"2016-08-18","scope":"insider"},{"id":3200545,"accession":"0000905148-16-001850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001850","line_url":"/filing/0000905148-16-001850#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58600.0,"shares_display":"58,600","price_per_share":16.2108,"price_display":"16.21","price_state":"stated","total_value":949952.88,"total_display":"949,952.88","total_whole":"949,953","shares_owned_after":1493380.0,"shares_owned_after_display":"1,493,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-18","scope":"insider"},{"id":2161959,"accession":"0000905148-16-001717","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001717","line_url":"/filing/0000905148-16-001717#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":19.7511,"price_display":"19.75","price_state":"stated","total_value":1975110.0,"total_display":"1,975,110.00","total_whole":"1,975,110","shares_owned_after":632780.0,"shares_owned_after_display":"632,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-30","filed_date":"2016-06-30","scope":"insider"},{"id":2161955,"accession":"0000905148-16-001717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001717","line_url":"/filing/0000905148-16-001717#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63700.0,"shares_display":"63,700","price_per_share":19.8282,"price_display":"19.83","price_state":"stated","total_value":1263056.34,"total_display":"1,263,056.34","total_whole":"1,263,056","shares_owned_after":532780.0,"shares_owned_after_display":"532,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-29","filed_date":"2016-06-30","scope":"insider"},{"id":2161952,"accession":"0000905148-16-001717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001717","line_url":"/filing/0000905148-16-001717#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":19.7372,"price_display":"19.74","price_state":"stated","total_value":17763.48,"total_display":"17,763.48","total_whole":"17,763","shares_owned_after":469080.0,"shares_owned_after_display":"469,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-28","filed_date":"2016-06-30","scope":"insider"},{"id":2646712,"accession":"0000905148-16-001704","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001704","line_url":"/filing/0000905148-16-001704#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21968.0,"shares_display":"21,968","price_per_share":19.1749,"price_display":"19.17","price_state":"stated","total_value":421234.2032,"total_display":"421,234.20","total_whole":"421,234","shares_owned_after":468180.0,"shares_owned_after_display":"468,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-27","filed_date":"2016-06-28","scope":"insider"},{"id":2646701,"accession":"0000905148-16-001704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001704","line_url":"/filing/0000905148-16-001704","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51435.0,"shares_display":"51,435","price_per_share":19.292972565373773,"price_display":"19.29","price_state":"stated","total_value":992334.0439,"total_display":"992,334.04","total_whole":"992,334","shares_owned_after":446212.0,"shares_owned_after_display":"446,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider","n_lines":2},{"id":2080295,"accession":"0000905148-16-001666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001666","line_url":"/filing/0000905148-16-001666#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4220.0,"shares_display":"4,220","price_per_share":17.6209,"price_display":"17.62","price_state":"stated","total_value":74360.198,"total_display":"74,360.20","total_whole":"74,360","shares_owned_after":394777.0,"shares_owned_after_display":"394,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":2080292,"accession":"0000905148-16-001666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001666","line_url":"/filing/0000905148-16-001666#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":17.5596,"price_display":"17.56","price_state":"stated","total_value":351192.0,"total_display":"351,192.00","total_whole":"351,192","shares_owned_after":390557.0,"shares_owned_after_display":"390,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":9206330,"accession":"0000905148-16-001815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001815","line_url":"/filing/0000905148-16-001815#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":802000.0,"shares_display":"802,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8822000.0,"total_display":"8,822,000.00","total_whole":"8,822,000","shares_owned_after":912969.0,"shares_owned_after_display":"912,969","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-08-09","scope":"insider"},{"id":2887790,"accession":"0001140361-16-068153","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001140361-16-068153","line_url":"/filing/0001140361-16-068153","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":251553.0,"shares_display":"251,553","price_per_share":12.698016382233565,"price_display":"12.70","price_state":"stated","total_value":3194224.115,"total_display":"3,194,224.12","total_whole":"3,194,224","shares_owned_after":295399.0,"shares_owned_after_display":"295,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-01","scope":"insider","n_lines":6},{"id":2161847,"accession":"0000905148-16-001653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001653","line_url":"/filing/0000905148-16-001653#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001402856","owner_name":"McGaughy R Kent Jr","owner_display_name":"McGaughy R Kent Jr","owner_url":"/insider/0001402856","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8035.0,"shares_display":"8,035","price_per_share":13.4199,"price_display":"13.42","price_state":"stated","total_value":107828.8965,"total_display":"107,828.90","total_whole":"107,829","shares_owned_after":370557.0,"shares_owned_after_display":"370,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":48,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001251769","name":"Apollo Endosurgery, Inc.","url":"/issuer/0001251769","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2017-07-26","last_seen":"2021-10-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001588978","name":"PROCEPT BioRobotics Corp","url":"/issuer/0001588978","role":"Ten percent owner","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001789769","name":"Instil Bio, Inc.","url":"/issuer/0001789769","role":"Director","n_filings":1,"first_seen":"2021-03-25","last_seen":"2021-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Director, Ten percent owner","n_filings":15,"first_seen":"2016-06-01","last_seen":"2019-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001402856","retrieved_at":"2026-08-22T22:24:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}